Skip to main content

Table 1 Baseline characteristics of the patients a

From: First national survival data for colorectal cancer among Saudis between 1994 and 2004: what’s next?

 

Cancer site

 

Colon (n, %)

Recto-sigmoid (n, %)

Rectum (n, %)

Number of patients

257 (46.8)

66 (12.0)

226 (41.2)

Age in years (Mean ± SD)

53.4 ± 14.7

53.6 ± 17.3

54.3 ± 15.2

Gender

Female

96 (51.6)

25 (13.4)

65 (34.9)

Male

161 (44.4)

41 (11.3)

161 (44.4)

Grade

Grade I (Well diff)

26 (44.8)

5 (8.6)

27 (46.6)

Grade II (Mod diff)

157 (44.7)

48 (13.7)

146 (41.6)

Grade III (Poor diff)

25 (46.3)

3 (5.6)

26 (48.1)

Grade IV (Undiff anaplastic)

4 (66.7)

0 (0)

2 (33.3)

Unknown

45 (56.3)

10 (12.5)

25 (31.3)

Extent b

Localized

48 (39.3)

14 (11.5)

60 (49.2)

Regional: Direct Ext

59 (54.6)

11 (10.2)

38 (35.2)

Regional: Lymph Node

12 (27.3)

9 (20.5)

23 (52.3)

Regional: Dir Ext and lymph node

64 (59.8)

9 (8.4)

34 (31.8)

Regional NOS

0 (0)

0 (0)

1 (100.0)

Distant Metastasis

63 (44.4)

21 (14.8)

58 (40.8)

Unknown

11 (44.0)

2 (8.0)

12 (48.0)

Status

Dead

152 (44.1)

43 (12.5)

150 (43.5)

Alive

105 (51.5)

23 (11.3)

76 (37.3)

Cause of death

Cancer

15 (62.5)

3 (12.5)

6 (25.0)

Unknown

137 (42.7)

40 (12.5)

144 (44.9)

Not applicable

105 (51.5)

23 (11.3)

76 (37.3)

  1. Abbreviations: Diff, differentiation; Dir, direct; Ext, extent; Mod, moderate; NOS, not otherwise specified; Undiff, undifferentiated.
  2. aData are presented as frequency (percent) unless otherwise specified.
  3. bp<0.05 for χ 2 test. Except for extent, the characteristics of the patients did not differ significantly among different cancer patients.